Financial Data and Key Metrics Changes - Revenue increased by 8.9% to $78.4 million, driven by growth in both MedTech and Med Device segments [13] - Adjusted EBITDA improved to $1.8 million from $1.3 million year-over-year, attributed to MedTech revenue growth and operational efficiency [18] - Gross margin for Q3 FY 2026 was 52.9%, a decrease of 110 basis points from the previous year, primarily due to tariffs and inflation [16] Business Line Data and Key Metrics Changes - MedTech revenue reached $37.3 million, a 19% increase, comprising 48% of total revenue compared to 44% a year ago [13] - Auryon platform generated $16.3 million in revenue, growing 17.9% year-over-year, marking 19 consecutive quarters of double-digit growth [13][14] - Mechanical thrombectomy revenue, including AngioVac and AlphaVac, increased by 17.9% to $11.5 million, with AlphaVac revenue growing 47.4% year-over-year [14] Market Data and Key Metrics Changes - The Med Device segment saw a modest increase of 1.1% year-over-year, with a year-to-date growth of 3% [15] - NanoKnife revenue increased by 21% to $7.6 million, driven by strong demand in prostate care and capital sales [15] Company Strategy and Development Direction - The company is focused on driving profitable growth in high-margin MedTech markets, with a strategic shift towards hospital settings [5][41] - Continued investment in R&D is planned, targeting approximately 10% of sales to support long-term growth [17] - The company is raising its full-year guidance for net sales and adjusted EBITDA for the third consecutive quarter, reflecting confidence in its growth strategy [21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the business despite macroeconomic challenges, including tariffs and inflation [5][19] - The company anticipates continued growth in the AlphaVac product line and expects to maintain strong performance in the MedTech segment [30][38] Other Important Information - The company plans to increase inventory levels in anticipation of temporary sterilization shutdowns, which may slightly impact cash flow [23][50] - The leadership transition process is underway, with a search committee formed to find a successor for the current CEO [24] Q&A Session Summary Question: AlphaVac sequential growth drivers and impact of PE guidelines - Management noted that growth is driven by new hospital approvals and physician comfort with the product, expecting continued sequential growth [29][30] Question: Guidance impact from higher energy costs and supplier costs - Management confirmed that guidance accounts for inflationary pressures and tariffs, with some ability to raise prices on superior products [32][33] Question: Future baseline for AlphaVac revenue - Management expects AlphaVac to continue growing sequentially, viewing current revenue as a strong driver for future growth [38] Question: Auryon volume versus price dynamics - Management highlighted the strategic shift towards hospital settings, which supports pricing and volume growth, and expects Auryon to continue growing [40][41] Question: Supply chain exposure to China and sterilization shutdowns - Management indicated minimal risk from China sourcing and noted that sterilization shutdowns are not frequent, with plans in place to mitigate any disruptions [48][50]

Financial Data and Key Metrics Changes - Cheche Group achieved adjusted net income of RMB 11.6 million or $1.7 million for the full year 2025, a significant improvement from an adjusted net loss of RMB 24.8 million in the prior year, marking a swing of over RMB 35 million [5][21] - Total written premiums increased by 11% year-over-year to RMB 27 billion or $3.9 billion for the full year 2025, with a total of 20.3 million policies issued, up from 17.3 million in the prior year [14][15] - The company reported a net revenue of RMB 3.0 billion or $430.4 million for the full year 2025, a decrease of 13.3% year-over-year, attributed to a higher proportion of NEV premiums [16] Business Line Data and Key Metrics Changes - NEV premiums represented 24.1% of total written premiums in the second half of 2025, up from 17.2% in the prior year period, indicating a shift towards higher margin business [15][16] - The number of NEV-embedded policies reached 2.0 million for the full year 2025, with corresponding premiums growing 91.0% to RMB 6.3 billion [15] Market Data and Key Metrics Changes - The company has established partnerships with 16 NEV manufacturers, generating significant growth in embedded policies and premiums [15] - Cheche Group is expanding its international presence, particularly in Asia and Latin America, leveraging its digital insurance and financial technology capabilities [12][33] Company Strategy and Development Direction - The company is transitioning from a transactional insurance platform to an AI-powered intelligent insurance ecosystem, focusing on enhancing operational capabilities through AI [4][6] - Cheche Group aims to deepen relationships with existing partners and expand its offerings within the NEV market, moving towards dynamic risk management [10][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the trajectory of the business, anticipating significant growth in NEV premiums and adjusted net income for 2026 [22] - The company is focused on cost management and operational efficiency, with total operating expenses decreasing by 19.6% for the full year 2025 [19] Other Important Information - The company reported RMB 160.8 million or $24.4 million in cash equivalents as of December 31, 2025, indicating a solid financial position [22] - Cheche Group plans to announce advancements in AI-driven auto pricing capabilities, which are expected to expand its addressable market [11] Q&A Session Summary Question: What will drive strong adoption of NEV premiums in 2026? - Management highlighted the integration of AI across workflows and the use of driving behavior data to enhance pricing, risk management, and fraud detection [30][32] Question: Can you explain your fintech solutions for international expansion? - The company has formed strategic partnerships with automotive brands and is leveraging its digital insurance capabilities to support Chinese automakers in their global expansion [33]

Financial Data and Key Metrics Changes - Revenue increased by 8.9% to $78.4 million, driven by growth in both MedTech and Med Device segments [13] - Adjusted EBITDA improved to $1.8 million from $1.3 million year-over-year, attributed to MedTech revenue growth and operational efficiency [18] - Gross margin for Q3 FY 2026 was 52.9%, a decrease of 110 basis points from the previous year, primarily due to tariffs and inflation [16] Business Line Data and Key Metrics Changes - MedTech revenue reached $37.3 million, a 19% increase year-over-year, comprising 48% of total revenue [13] - Auryon platform generated $16.3 million in revenue, growing 17.9% year-over-year, marking 19 consecutive quarters of double-digit growth [13] - Mechanical thrombectomy revenue, including AngioVac and AlphaVac, increased by 17.9% to $11.5 million, with AlphaVac revenue growing 47.4% year-over-year [14] Market Data and Key Metrics Changes - The Med Device segment saw a modest increase of 1.1% year-over-year, with a year-to-date growth of 3% [15] - NanoKnife revenue increased by 21% to $7.6 million, driven by strong demand in prostate care [15] Company Strategy and Development Direction - The company is focused on driving profitable growth in high-margin MedTech markets, with a strategic shift towards hospital settings [5][41] - Continued investment in R&D is planned, targeting approximately 10% of sales to support long-term growth [17] - The company is raising full-year guidance for net sales and adjusted EBITDA for the third consecutive quarter, reflecting confidence in growth strategies [20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the business despite macroeconomic uncertainties and challenges such as tariffs and inflation [5] - The company anticipates continued growth in the mechanical thrombectomy market and expects to maintain strong performance in the MedTech segment [9][38] Other Important Information - The company plans to increase inventory levels in anticipation of temporary sterilization shutdowns, which may slightly impact cash flow [23] - The leadership transition process is underway, with a search committee formed to find a successor for the CEO [24] Q&A Session Summary Question: What are the drivers behind AlphaVac's sequential growth? - Management noted that the growth is driven by increased hospital approvals and physician comfort with the product, expecting continued sequential growth [28][30] Question: Has the guidance accounted for higher energy costs and supplier costs? - Management confirmed that guidance includes expectations for inflationary costs and tariffs, with some ability to raise prices on superior products [32][33] Question: Should the $4.4 million AlphaVac revenue be viewed as a new baseline? - Management expects AlphaVac to continue growing sequentially, viewing the current revenue as a strong driver for future growth [38] Question: Can you provide insights on Auryon's performance in hospitals versus OBL? - Management highlighted a strategic shift towards hospital settings, which has positively impacted pricing and volume, while still maintaining growth in OBL [41][42] Question: What proportion of MedTech costs are exposed to China sourcing? - Management indicated that there is minimal risk from China sourcing, and inflationary impacts are being managed effectively [48]

LEG Immobilien SE Company Presentation April 2026 FY 2025 Company Presentation 1 FY-2025 Highlights Company Presentation March 2026 – LEG Immobilien SE 2 2 LEG at a Glance 3 Portfolio & Operations 4 Management 5 ESG 6 Financials 7 Financing Share information, Financial calendar & IR contact 8 LEG Immobilien SE Disclaimer LEG Immobilien SE ("The Company") has taken all reasonable care to ensure that the facts stated in this presentation are accurate and that the opinions expressed therein are fair and reason ...

Financial Data and Key Metrics Changes - For the full year 2025, the company delivered net sales and comparable store sales growth of 1%, marking the first year of positive comparable store sales growth since 2020 [16] - Adjusted EBITDA for the year was $27.5 million, modestly below the prior year but exceeding revised expectations [16] - Net loss for Q4 was $21.7 million, or $0.56 per diluted share, compared to a net loss of $8.7 million, or $0.23 per diluted share in the prior year [20] - Adjusted net loss for Q4 was $3.9 million or negative $0.10 per diluted share, compared with adjusted net income of $1.6 million or $0.04 per diluted share in Q4 of the prior year [20] - Gross margin for Q4 was 28.4% compared to 30.4% last year, primarily driven by category mix and increased promotional activity [19] Business Line Data and Key Metrics Changes - Fishing remained the strongest growth driver in 2025, increasing 10.3% for the year and nearly 18% on a two-year stack basis [17] - Hunting and shooting sports increased 4.4% for the year, driven by improved in-stock levels in core firearms and ammunition [17] - E-commerce business outperformed with sales up 8.3% in Q4 and 6.6% for the year, highlighting the strength of the omni-channel model [8] Market Data and Key Metrics Changes - The company experienced a more pressured promotional environment in the first half of Q4, but sales trends turned positive in the latter half of the quarter [4] - The U.S. consumer remains under pressure due to rising fuel costs and broader macro dynamics, impacting discretionary spending [14] Company Strategy and Development Direction - The company is focused on strengthening its leadership position in core pursuits: fishing, hunting and shooting sports, and personal protection [10] - Strategic initiatives for 2026 include upgrading the loyalty rewards program, developing firearm solution bundling, and reinventing the omni-channel fishing experience [11][12][13] - The company aims to manage inventory efficiently and use excess free cash flow to pay down debt and strengthen the balance sheet [23] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the positioning and traction of strategic initiatives, despite acknowledging the pressure on U.S. consumers [15] - The company is capturing demand in personal protection ammo, driven by external factors, while remaining realistic about the duration of this demand [14] - Management highlighted potential tailwinds, such as America's 250th anniversary, which aligns well with customer interests [14] Other Important Information - The company ended 2025 with inventory down $29.1 million or 8.5% year-over-year, indicating improved inventory management [16] - Capital expenditures for the full year were approximately $19.5 million, primarily focused on store maintenance and strategic technology investments [21] - The company plans to close approximately 5 underperforming stores in the next 12 months, with no material impact expected on this year's results [22] Q&A Session Summary Question: Near term demand trends and category strength - Management noted strong growth in firearms and ammunition, with positive trends continuing through Q1 [25][26] Question: Building blocks for EBITDA improvement - Management expects slight improvements in margins for the rest of the year, despite pressures from category mix [27][29] Question: Free cash flow and inventory balance - Management indicated opportunities for inventory efficiency and plans to manage inventory timing better [31][32] Question: Risks from external events affecting consumer demand - Management acknowledged the health of the U.S. consumer as a risk but noted potential tailwinds from external events [39][40] Question: Future margin outlook and category penetration - Management is working on improving the mix of categories to support margin recovery while focusing on fishing and soft goods [42][43]

Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $0.4 million, compared to $0.2 million in Q4 2024, representing a year-over-year increase of 100% [19] - For the full year 2025, total revenue was $2.0 million, up from $0.9 million in 2024, indicating a year-over-year increase of 129% [19] - Net loss for Q4 2025 was $4.0 million, an improvement from a net loss of $4.6 million in Q4 2024 [20] - Full-year net loss was $17.9 million, compared to $14.3 million in the previous year [20] - Adjusted EBITDA loss for Q4 was $3.0 million, compared to a loss of $4.1 million in Q4 2024 [24] Business Line Data and Key Metrics Changes - The core business saw significant growth, with underlying revenue in Q4 being over two times that of the previous year, at $406 thousand versus $200 thousand [15] - Annual recurring revenue (ARR) as of Q4 was $1.8 million, compared to $0.8 million for the same period last year [24] - Booked annual recurring revenue (BAR) for Q4 was $0.1 million, down from $7.1 million a year ago, primarily due to longer sales cycles [25] Market Data and Key Metrics Changes - The company is engaged with top players across various industries, including financial services, technology, and healthcare, indicating strong market interest [6][10] - The company has a pipeline of over $30 million in active engagements with large enterprise accounts [16] Company Strategy and Development Direction - The company is focused on enhancing its technology to meet market demands, particularly in identity verification and AI security [11][12] - Strategic partnerships have been established with major firms, including a top 20 global retailer and MajorKey Technologies, to expand market reach [8][9] - The company aims to leverage its proprietary technology to address the urgent identity security challenges faced by enterprises [4][5] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growing market demand for identity solutions and the company's ability to secure significant enterprise clients [16][18] - The company anticipates resuming growth in remaining performance obligations (RPO) as it closes additional enterprise deals [23][27] - Management acknowledged challenges from earlier customer contracts but emphasized the company's ability to acquire new enterprise customers and deliver value [29] Other Important Information - The company was accepted into the NVIDIA Connect program, enhancing its access to AI and machine learning frameworks [13] - The company has launched several new platforms and partnerships aimed at improving identity verification and security for enterprises [17][18] Q&A Session Summary Question: What are the expectations for future revenue growth? - Management indicated that while 2025 faced challenges, the company is positioned for significant growth in 2026 as it capitalizes on momentum from product development and partnerships [29] Question: How is the company addressing the longer sales cycles? - Management noted that the excitement and demand for privacy-preserving biometric solutions are growing, and they remain committed to closing enterprise deals [27]

Financial Data and Key Metrics Changes - Total company net revenues decreased by 19.7% to $61.6 million in Q4 2025 from $76.7 million in the same period last year, primarily driven by a 22.4% decrease in volume of products sold [21][22] - Gross profit was $1.4 million with a gross margin of 2.3%, compared to a gross profit of $10 million and a gross margin of 13.1% in the year-ago period [26] - Net income was reported at $409.9 million in Q4 2025, a significant increase from a net loss of $44.9 million in the previous year, largely due to a $548.7 million gain on debt restructuring [10][29] Business Line Data and Key Metrics Changes - U.S. retail channel net revenues decreased by 6.5% to $31.7 million, primarily volume-driven, while net revenue per pound remained flat [23] - U.S. food service net revenues decreased by 23.7% to $8 million, driven by a 25.1% decrease in volumes sold [24] - International retail channel net revenues decreased by 32.5% to $8.8 million, primarily due to a 33.5% decrease in volume sold [25] Market Data and Key Metrics Changes - The overall demand for plant-based meat products remains weak, impacting sales across key geographies and channels [21][22] - The company is experiencing challenges in both U.S. and international markets, particularly with reduced sales of chicken and burger products to QSR customers [21][24][25] Company Strategy and Development Direction - The company is repositioning itself from Beyond Meat to Beyond, the plant protein company, to expand into adjacent categories such as beverages [6][16] - A focus on reducing operating expenses and improving cash management is emphasized, with ongoing efforts to optimize production and logistics [11][12] - The launch of the Beyond Immerse beverage platform aims to leverage the company's expertise in plant-based ingredients while addressing consumer health needs [17][19] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenging operating environment and weak demand in the plant-based meat category, but remains optimistic about future recovery and growth opportunities [5][34] - The company plans to provide limited guidance for Q1 2026, expecting net revenues to be approximately $57 million to $59 million, reflecting ongoing uncertainty [34] Other Important Information - The company has identified material weaknesses in internal controls over financial reporting, particularly related to inventory provisions, and is actively working on remediation plans [35][36] - The company is considered an untimely filer due to delays in filing its annual report, which affects its eligibility for certain registration statements [37] Q&A Session Summary Question: Outlook for new products and diversification - Management clarified that the pivot towards new product lines does not abandon the original mission but broadens the business focus to meet consumer needs [40][42] Question: Cash flow management and operational leverage - Management discussed ongoing efforts to manage working capital and inventory levels to reduce cash burn, with expectations for improved cash consumption in 2026 [53][56] Question: Beverage product supply chain and production - Management indicated that the supply chain for the beverage category is manageable, leveraging existing expertise and co-packing agreements [72][74] Question: Scaling beverage expansion and distribution - A careful approach will be taken to scale the beverage category, initially launching direct-to-consumer and gradually expanding distribution based on consumer feedback [80][81]

Financial Data and Key Metrics Changes - In Q4 2025, total revenues increased to $1.93 million from $1.79 million in Q4 2024, driven by higher product sales and increased grant revenues [10] - Year-to-date revenues for FY 2025 were $4.79 million, down from $5.29 million in the prior year, primarily due to lower service revenues related to the Fresno EV infrastructure project [11] - Margins on products, services, and grant revenues improved to 24.2% in Q4 2025 from 15.8% in the same period last year, with year-to-date margins at 39.1% compared to 33.1% [11] - Net loss attributable to common stockholders increased to $6.1 million in Q4 2025 from $5.1 million in Q4 2024, mainly due to a one-time inventory impairment charge [15] - Cash as of December 31, 2025, was approximately $5.5 million, an increase of $5.1 million from December 2024 [16] Business Line Data and Key Metrics Changes - The company is transitioning from vehicle-to-grid deployments to stationary storage, with a focus on battery management and AI integration [3][4] - Three battery projects in Europe were announced, totaling 150 MW, with compensation varying significantly per MW [5] - In Japan, a 2 MW battery sale was announced for $3.35 million, with additional projects in the pipeline [6][7] Market Data and Key Metrics Changes - Megawatts under management increased by 7.5% quarter-over-quarter to 28.3 MW, but decreased by 7.6% year-over-year [19] - The U.S. battery projects are progressing slower compared to those in Europe and Japan, influenced by geopolitical factors [8] Company Strategy and Development Direction - The company is pivoting towards stationary battery deployments, which is seen as a strategic move supported by market signals [4][22] - A partnership with Omnia Global aims to deploy over 1 GW of battery capacity across Europe in the next 24 months [4] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the pivot towards stationary storage and anticipates significant developments in battery deployments, particularly in Europe and Japan [22] - The company expects improvements in cash burn due to lower operating costs compared to the previous year [21] Other Important Information - An inventory impairment charge of $3.47 million was recognized due to non-conforming DC chargers, impacting the financial results significantly [13] - The backlog of hardware and service decreased to $3.3 million, down from $18.3 million a year ago, primarily due to the termination of the Fresno project [20] Q&A Session Summary - No questions were raised during the Q&A session, leading to the conclusion of the call [23]

Financial Data and Key Metrics Changes - Total company net revenues decreased by 19.7% to $61.6 million in Q4 2025 from $76.7 million in the year-ago period, primarily driven by a 22.4% decrease in volume of products sold [21][22] - Gross profit in Q4 2025 was $1.4 million, resulting in a gross margin of 2.3%, compared to a gross profit of $10 million and a gross margin of 13.1% in the year-ago period [26] - Net income for Q4 2025 was $409.9 million, or $0.84 per common share, compared to a net loss of $44.9 million, or a loss of $0.65 per common share in the year-ago period [29] Business Line Data and Key Metrics Changes - U.S. retail channel net revenues decreased by 6.5% to $31.7 million in Q4 2025, primarily volume-driven, reflecting weak category demand [23] - U.S. food service net revenues decreased by 23.7% to $8 million, driven by a 25.1% decrease in volumes of products sold [24] - International retail channel net revenues decreased by 32.5% to $8.8 million, primarily due to a 33.5% decrease in volume of products sold [25] Market Data and Key Metrics Changes - The overall plant-based meat category continues to experience weak demand, impacting sales across various channels [8][21] - The company noted a decrease in sales of chicken and burger products to QSR customers both in the U.S. and abroad, contributing to the decline in revenues [21] Company Strategy and Development Direction - The company is repositioning itself from Beyond Meat to Beyond, the plant protein company, to leverage its brand and technology in adjacent categories [6][19] - A focus on reducing baseline operating expenses, increasing production efficiency, and addressing category headwinds is emphasized as part of the transformation initiative [8][11] - The launch of the new beverage platform, Beyond Immerse, is part of the strategy to expand into adjacent markets and diversify the product portfolio [17][19] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenging operating environment and the need for a cautious approach to guidance, citing low visibility within the core plant-based meat category [34] - The company is optimistic about the potential for recovery and stabilization in the U.S. retail segment, which could positively impact overall performance [74] - Management expressed confidence in the long-term prospects of the plant-based category despite current challenges, emphasizing the importance of innovation and clean ingredients [19][48] Other Important Information - The company has identified material weaknesses in internal controls over financial reporting, particularly related to inventory provisions, and is actively working on remediation plans [35][36] - The company is considered an untimely filer due to delays in filing its annual report, which may impact its ability to use certain registration statements until it regains timely filer status [37] Q&A Session Summary Question: Outlook for new products and diversification - Management clarified that the pivot towards new product lines does not abandon the original mission but broadens the business focus to meet consumer needs [40][42] Question: Cash flow management and operational efficiency - Management discussed ongoing efforts to manage working capital and inventory levels to reduce cash burn, with expectations for improved cash consumption in 2026 [53][56] Question: Beverage product supply chain and production - Management indicated that the supply chain for the beverage category is manageable, leveraging existing expertise and co-packing agreements to facilitate production [75][76] Question: Scaling beverage expansion and distribution - A careful approach will be taken to scale the beverage category, starting with direct-to-consumer sales and gradually expanding distribution based on consumer feedback [81][82] Question: SKU rationalization and core product focus - Management emphasized a focus on high-value products that align with the clean ingredient narrative, while retrenching from less differentiated items [85][86]

Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $0.4 million, compared to $0.2 million in Q4 2024, representing a year-over-year increase of 100% [32] - For the full year 2025, total revenue was $2.0 million, up from $0.9 million in 2024, indicating a year-over-year increase of 129% [32] - Net loss for Q4 2025 was $4.0 million, an improvement from a net loss of $4.6 million in Q4 2024 [34] - Adjusted EBITDA loss for Q4 2025 was $3.0 million, compared to a loss of $4.1 million in the same period last year [36] - Annual recurring revenue (ARR) as of Q4 2025 was $1.8 million, up from $0.8 million in Q4 2024 [37] Business Line Data and Key Metrics Changes - The core business, which includes customers who are live, ramping, and paying, grew substantially, with underlying revenue in Q4 being over 2x what it was a year ago [25] - The gross booked annual recurring revenue (bARR) for Q4 2025 was $0.1 million, down from $7.1 million in Q4 2024, primarily due to longer sales cycles for enterprise deals [38] Market Data and Key Metrics Changes - The company has a pipeline of over $30 million in active engagements with a significant number of large enterprise accounts, indicating strong market demand [26] - The remaining performance obligation (RPO) as of December 31, 2025, was $2.2 million, a decrease from $3.6 million in the previous quarter [35] Company Strategy and Development Direction - The company is focusing on expanding its partnerships and technology deployments, including a full production agreement with a major European retail chain and collaborations with MajorKey Technologies and NESIC [13][14][15] - The company aims to leverage its proprietary technology to address the urgent identity security issues faced by enterprises, particularly in the context of AI and deepfake threats [7][8][11] Management's Comments on Operating Environment and Future Outlook - Management expressed excitement about the increasing market interest in the company's technology, highlighting that major enterprises are actively seeking solutions to identity security challenges [7][9] - The company anticipates resuming RPO growth in 2026 as it gains traction in closing additional enterprise deals [35][42] Other Important Information - The company was accepted into the NVIDIA Connect program, which will enhance its development capabilities in AI and machine learning [23] - The company has made significant advancements in its technology, including the launch of the authID Mandate Framework for AI security [21] Q&A Session Summary - No specific questions or answers were provided in the content regarding the Q&A session.